KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Incyte (INCY) over the last 14 years, with Sep 2025 value amounting to -$12.2 million.

  • Incyte's Gains from Investment Securities fell 152.13% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.3 million, marking a year-over-year decrease of 40.63%. This contributed to the annual value of $373.1 million for FY2024, which is 1.36% down from last year.
  • Incyte's Gains from Investment Securities amounted to -$12.2 million in Q3 2025, which was down 153.62% from $22.8 million recorded in Q2 2025.
  • In the past 5 years, Incyte's Gains from Investment Securities registered a high of $125.0 million during Q4 2023, and its lowest value of -$21.9 million during Q3 2022.
  • Over the past 3 years, Incyte's median Gains from Investment Securities value was $8.4 million (recorded in 2023), while the average stood at $23.9 million.
  • In the last 5 years, Incyte's Gains from Investment Securities crashed by 852.34% in 2022 and then spiked by 5,595.31% in 2024.
  • Quarterly analysis of 5 years shows Incyte's Gains from Investment Securities stood at $21.9 million in 2021, then declined by 9.85% to $19.7 million in 2022, then spiked by 534.49% to $125.0 million in 2023, then crashed by 43.85% to $70.2 million in 2024, then slumped by 152.13% to -$12.2 million in 2025.
  • Its Gains from Investment Securities was -$12.2 million in Q3 2025, compared to $22.8 million in Q2 2025 and $11.6 million in Q1 2025.